Richard Kent has become president and CEO of Serenex, based in Durham, NC. He succeeds Robert Dishman, the company’s founding president, CEO, and chairman.
Prior to joining Serenex, Kent was president and CEO of Ardent Pharmaceuticals. Before that, he held various positions at GlaxoSmith-Kline, including vice president for US medical operations, group medical director, vice president for global medical affairs, and chief medical officer.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
